Anpario (GB:ANP)
LSE:ANP
Want to see GB:ANP full AI Analyst Report?
ANP Stock Chart & Stats
480.00 p
-3.45 p(-0.92%)
At close: 4:00 PM EST
480.00 p
-3.45 p(-0.92%)
Day’s Range― - ―
52-Week Range370.00 p - 580.00 p
Previous CloseN/A
Volume2.56K
Average Volume (3M)42.81K
Market Cap
£85.47M
Enterprise Value72.48M
Total Cash (Recent Filing)£12.41M
Total Debt (Recent Filing)£244.00K
Price to Earnings (P/E)12.8
Beta1.11
Next Earnings
Sep 16, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2.42%
Share Statistics
EPS (TTM)0.40
Shares Outstanding20,229,847
10 Day Avg. Volume33,956
30 Day Avg. Volume42,812
Financial Highlights & Ratios
PEG Ratio0.20
Price to Book (P/B)1.95
Price to Sales (P/S)1.69
P/FCF Ratio14.62
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
£570.00Price Target Upside18.75% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)0.42
Revenue Forecast (FY)£50.35M
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetNear-zero leverage materially reduces financial risk and preserves optionality. A strong equity base and improving ROE (~16.5% in 2025) give the company durable capacity to fund organic growth, withstand agricultural cycles, pay dividends, and pursue selective investments without relying on external debt.
Strong Multi-year Revenue GrowthSustained, rapid top-line growth demonstrates expanding market penetration across end-markets and supports scale advantages. Consistent revenue expansion improves gross profit potential, funds R&D and market entry costs, and underpins longer-term margin recovery if cost discipline and pricing power persist.
Healthy Free Cash Flow GenerationPositive and material free cash flow in 2025 provides the company with durable internal funding for capex, working capital and dividends. Reliable cash generation enhances financial flexibility, lowers need for external financing, and supports reinvestment into distribution and product development.
Bears Say
Margin VolatilityMeaningful swings in margins reduce earnings predictability and can signal sensitivity to input costs, competitive pricing or product mix shifts. Persistent margin pressure would undermine return on capital and could limit the company’s ability to convert revenue growth into lasting profitability improvements.
Episodic Cash-flow VariabilityIntermittent gaps between reported earnings and cash generation highlight working-capital or timing risks. Such volatility can strain liquidity during downcycles, constrain discretionary spending, and make dividend or capital allocation plans less predictable over a multi-quarter horizon.
Dependence On Non-antibiotic AdoptionRevenue growth is structurally tied to farmer and integrator adoption of non-antibiotic additives. Slower regulatory or customer shifts toward these alternatives, or competitive product wins, would materially slow volume growth and limit the durability of recent top-line gains.
Anpario News
ANP FAQ
What was Anpario’s price range in the past 12 months?
Anpario lowest share price was 370.00 p and its highest was 580.00 p in the past 12 months.
What is Anpario’s market cap?
Anpario’s market cap is £85.47M.
When is Anpario’s upcoming earnings report date?
Anpario’s upcoming earnings report date is Sep 16, 2026 which is in 90 days.
How were Anpario’s earnings last quarter?
Anpario released its earnings results on Mar 31, 2026. The company reported 0.238 p earnings per share for the quarter, beating the consensus estimate of N/A by 0.238 p.
Is Anpario overvalued?
According to Wall Street analysts Anpario’s price is currently Undervalued.
Does Anpario pay dividends?
Anpario pays a Notavailable dividend of 8.9 p which represents an annual dividend yield of 2.42%. See more information on Anpario dividends here
What is Anpario’s EPS estimate?
Anpario’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Anpario have?
Anpario has 20,229,847 shares outstanding.
What happened to Anpario’s price movement after its last earnings report?
Anpario reported an EPS of 0.238 p in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 6.395%.
Which hedge fund is a major shareholder of Anpario?
Currently, no hedge funds are holding shares in GB:ANP
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Anpario Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
£570.00 (18.75% Upside)
£570.00 (18.75% Upside)
Blogger Sentiment
Bullish
GB:ANP Sentiment 100%
Sector Average ―
Sector Average ―
Technicals
SMA
Positive
20 days / 200 days
Momentum
57.23%
12-Months-Change
Fundamentals
Return on Equity
16.88%
Trailing 12-Months
Asset Growth
7.09%
Trailing 12-Months
Company Description
Anpario
Anpario plc, founded in 1996 and based in Worksop, United Kingdom, specializes in the global production and distribution of natural feed additives designed to enhance animal health, hygiene, and nutrition. Previously operating as Kiotech International plc until its rebranding in November 2011, the company offers a diverse product portfolio across several categories. Its 'Health and Performance' line features products that bolster animal gut health, including phytogenic and acid-based eubiotics, and omega fatty acids, available under brands such as Orego-Stim, Optomega, pHorce, Salgard, Salkil, Genex, and Optimax. The 'Feed Quality' segment provides solutions like enzymes, antioxidants, pellet binders, mould inhibitors, and acid-based eubiotics, marketed as pHorce, Salkil, Salgard, Oxigard, Moldgard, and Mastercube. For 'Hygiene and Insect Control', Anpario supplies water sanitation tablets, all-natural insect control powders, and natural drying agents, sold under names like Credence, Mitex, Red Lite, and Clean & Dry, which contribute to minimizing environmental microbial burdens and supporting animal gut health and overall performance. Furthermore, the 'Toxin Management' category offers mycotoxin binders, including products under the Anpro, Ultrabond, and Neutox brands. Anpario plc maintains a broad international footprint, conducting operations across the Americas, Asia, Europe, the Middle East, and Africa.
ANP Stock 12 Month Forecast
Average Price Target
570.00 p
▲(18.75% Upside)
Technical Analysis
Options Prices
Currently, No data available
---